{"id":"https://openalex.org/W43290813","doi":"https://doi.org/10.3185/pathexo3235","title":"[Change of antimalarial first-line treatment in Burkina Faso in 2005].","display_name":"[Change of antimalarial first-line treatment in Burkina Faso in 2005].","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W43290813","doi":"https://doi.org/10.3185/pathexo3235","mag":"43290813","pmid":"https://pubmed.ncbi.nlm.nih.gov/19343918"},"language":"fr","primary_location":{"id":"doi:10.3185/pathexo3235","doi":"https://doi.org/10.3185/pathexo3235","is_oa":false,"landing_page_url":"https://doi.org/10.3185/pathexo3235","pdf_url":null,"source":{"id":"https://openalex.org/S85516562","display_name":"Bulletin de la Soci\u00e9t\u00e9 de pathologie exotique","issn_l":"0037-9085","issn":["0037-9085","1961-9049"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1","poland-20"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin de la Soci\u00e9t\u00e9 de pathologie exotique","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007866259","display_name":"Adama Gansan\u00e9","orcid":"https://orcid.org/0000-0002-5364-530X","observed_orcids":["https://orcid.org/0000-0002-5364-530X"]},"institutions":[{"id":"https://openalex.org/I4210143827","display_name":"Centre National de Recherche et de Formation sur le Paludisme","ror":"https://ror.org/03y3jby41","country_code":"BF","type":"facility","lineage":["https://openalex.org/I4210143827"]}],"countries":["BF"],"is_corresponding":true,"raw_author_name":"A. Gansan\u00e9","raw_affiliation_strings":["Centre national de recherche et de formation sur le paludisme, BP 2208 Ouagadougou 01, Burkina Faso"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre national de recherche et de formation sur le paludisme, BP 2208 Ouagadougou 01, Burkina Faso","institution_ids":["https://openalex.org/I4210143827"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007866259"],"corresponding_institution_ids":["https://openalex.org/I4210143827"],"apc_list":null,"apc_paid":null,"fwci":1.0168,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.781468,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"102","issue":"1","first_page":"31","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12685","display_name":"Phytochemical compounds biological activities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimalarial-drug-policy","display_name":"antimalarial drug policy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/first-line-antimalarial-treatment","display_name":"first-line antimalarial treatment","score":0.7730000019073486},{"id":"https://openalex.org/keywords/chloroquine","display_name":"chloroquine","score":0.781000018119812},{"id":"https://openalex.org/keywords/sulfadoxine-pyrimethamine","display_name":"sulfadoxine-pyrimethamine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/falciparum-malaria","display_name":"falciparum malaria","score":0.8700000047683716},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.6330000162124634},{"id":"https://openalex.org/keywords/in-vivo-efficacy","display_name":"in vivo efficacy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/uncomplicated-malaria","display_name":"uncomplicated malaria","score":0.722000002861023},{"id":"https://openalex.org/keywords/children-under-five","display_name":"children under five","score":0.7390000224113464},{"id":"https://openalex.org/keywords/burkina-faso","display_name":"Burkina Faso","score":0.968999981880188}],"concepts":[{"id":"https://openalex.org/C2778301690","wikidata":"https://www.wikidata.org/wiki/Q411557","display_name":"Sulfadoxine","level":5,"score":0.868645191192627},{"id":"https://openalex.org/C2780441369","wikidata":"https://www.wikidata.org/wiki/Q421072","display_name":"Sulfadoxine/pyrimethamine","level":5,"score":0.863017737865448},{"id":"https://openalex.org/C2778629330","wikidata":"https://www.wikidata.org/wiki/Q904464","display_name":"Artemether/lumefantrine","level":5,"score":0.7565680742263794},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.7242663502693176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7088724970817566},{"id":"https://openalex.org/C2778059366","wikidata":"https://www.wikidata.org/wiki/Q707939","display_name":"Artesunate","level":4,"score":0.6818962097167969},{"id":"https://openalex.org/C2776992834","wikidata":"https://www.wikidata.org/wiki/Q239569","display_name":"Amodiaquine","level":4,"score":0.6747936606407166},{"id":"https://openalex.org/C2777035104","wikidata":"https://www.wikidata.org/wiki/Q421072","display_name":"Pyrimethamine","level":4,"score":0.6482201814651489},{"id":"https://openalex.org/C2777425658","wikidata":"https://www.wikidata.org/wiki/Q422438","display_name":"Chloroquine","level":3,"score":0.6453054547309875},{"id":"https://openalex.org/C2778118209","wikidata":"https://www.wikidata.org/wiki/Q416199","display_name":"Artemether","level":5,"score":0.6149866580963135},{"id":"https://openalex.org/C2780780316","wikidata":"https://www.wikidata.org/wiki/Q904464","display_name":"Lumefantrine","level":5,"score":0.581169843673706},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.4913124144077301},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3897554278373718},{"id":"https://openalex.org/C2776120307","wikidata":"https://www.wikidata.org/wiki/Q426921","display_name":"Artemisinin","level":4,"score":0.2757517397403717},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11827641725540161}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002050","descriptor_name":"Burkina Faso","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002738","descriptor_name":"Chloroquine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008288","descriptor_name":"Malaria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010961","descriptor_name":"Plasmodium","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011248","descriptor_name":"Pregnancy Complications","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D011248","descriptor_name":"Pregnancy Complications","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011739","descriptor_name":"Pyrimethamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013413","descriptor_name":"Sulfadoxine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3185/pathexo3235","doi":"https://doi.org/10.3185/pathexo3235","is_oa":false,"landing_page_url":"https://doi.org/10.3185/pathexo3235","pdf_url":null,"source":{"id":"https://openalex.org/S85516562","display_name":"Bulletin de la Soci\u00e9t\u00e9 de pathologie exotique","issn_l":"0037-9085","issn":["0037-9085","1961-9049"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1","poland-20"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin de la Soci\u00e9t\u00e9 de pathologie exotique","raw_type":"journal-article"},{"id":"pmid:19343918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19343918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin de la Societe de pathologie exotique (1990)","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2464417828"],"related_works":["https://openalex.org/W2103675613","https://openalex.org/W2429655888","https://openalex.org/W1996917976","https://openalex.org/W2150488868","https://openalex.org/W2529504656","https://openalex.org/W7097355044","https://openalex.org/W2077423977","https://openalex.org/W7097654719","https://openalex.org/W2166597257","https://openalex.org/W2079343056"],"abstract_inverted_index":{"Burkina":[0,57,142],"Faso":[1,143],"has":[2],"recently":[3],"changed":[4],"the":[5,14,21,29,110,135],"antimalarial":[6,16],"drug":[7,17],"policy":[8,140],"to":[9,60,81,89],"artesunate/amodiaquine":[10],"or":[11,44,69],"artemether/lumefantrine":[12],"as":[13],"first-line":[15],"and":[18,83,120,126],"sulfadoxine/pyrimethamine":[19,45,70],"for":[20,46,124],"intermittent":[22],"preventive":[23],"treatment":[24,47,114],"in":[25,38,53,93,141,144],"pregnant":[26],"woman.":[27],"Before":[28],"implementation":[30],"of":[31,48,56,137],"this":[32],"new":[33],"strategy":[34],"we":[35],"conducted":[36],"an":[37],"vivo":[39],"efficacy":[40],"study":[41],"with":[42,130],"chloroquine":[43,125],"uncomplicated":[49],"Plasmodium":[50],"falciparum":[51],"malaria":[52,138],"urban":[54],"area":[55],"from":[58,87],"September":[59],"December":[61],"2003.":[62],"Chloroquine":[63],"(25":[64,71],"mg/kg":[65,72,75],"over":[66,101],"3":[67],"days)":[68],"+":[73],"0.025":[74],"single":[76],"dose)":[77],"was":[78],"administered":[79],"respectively":[80,123],"137":[82],"125":[84],"children":[85],"aged":[86],"6":[88],"59":[90],"months":[91],"old":[92],"a":[94],"randomized,":[95],"opened":[96],"study.":[97],"Follow":[98],"up":[99],"extended":[100],"28":[102],"days":[103],"using":[104],"modified":[105],"WHO":[106],"protocol.":[107],"After":[108],"adjusting":[109],"results":[111,129],"by":[112],"PCR,":[113],"failures":[115],"rates":[116],"were":[117],"63.4%":[118],"(83/131)":[119],"13.8%":[121],"(17/123)":[122],"sulfadoxine/pyrimethamine.":[127],"These":[128],"other":[131],"observations":[132],"have":[133],"justified":[134],"change":[136],"therapy":[139],"2005.":[145]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}